Evidence map›Paper›PMID 34234190›Full record

ArticleScientific reports2021

Scientists have favorable opinions on immunity certificates but raise concerns regarding fairness and inequality.

Iván Aranzales, Ho Fai Chan, Reiner Eichenberger, Rainer Hegselmann, David Stadelmann, Benno Torgler

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Public views on the Covid-19 immunity certificate: A scoping review.Health expectations : an international journal of public participation in health care and health policy · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Iván AranzalesSchool of Economics and Finance, Queensland University of Technology, Brisbane, QLD, Australia.
Ho Fai ChanSchool of Economics and Finance, Queensland University of Technology, Brisbane, QLD, Australia.
Reiner EichenbergerUniversity of Fribourg, Fribourg, Switzerland.
Rainer HegselmannFrankfurt School of Finance & Management, Frankfurt, Germany.
David StadelmannCentre for Behavioural Economics, Society and Technology (BEST), Brisbane, QLD, Australia. david.stadelmann@uni-bayreuth.de.
Benno TorglerSchool of Economics and Finance, Queensland University of Technology, Brisbane, QLD, Australia.

Funding

Australian Research Council DP180101169DFG, German Research Foundation EXC 2052/1 - 390713894
6 · The paper itself

Abstract

During the first wave of the COVID-19 pandemic, we collected over 12,000 responses from a survey of scientists, who were asked to express their opinions on immunity certificates (also called "immunity passports") as a potential instrument to lessen the impact of the crisis. Overall, we find that scientists perceive immunity certificates as favorable for public health (50.2%) and the state of the economy (54.4%) while one-fifth (19.1%) and one-sixth (15.4%) disagree. Scientists stipulate some concerns about fairness (36.5%) and inequality (22.4%) arising from implementation of immunity certification. We find some smaller differences among scientific fields, particularly between health scientists and social scientists, with the latter being slightly more positive about the effect of immunity certification. Scholars in the United States, including health scientists, are more likely to view the immunity certificates favorably and mention fewer concerns about this policy's effect on fairness and inequality. Female scholars are significantly less in favor of immunity certificates, while scientists with more conservative political views hold more favorable opinions. Our results reveal that given the uncertainties during an early phase of a pandemic, scientists see scope for immunity certification to lessen the general societal impacts of the crisis.

Identifiers

PMID34234190
PMCPMC8263576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.